Quantifying blood‐brain barrier leakage in small vessel disease: Review and consensus recommendations

Abstract

Cerebral small vessel disease (cSVD) comprises pathological processes of the small vessels in the brain that may manifest clinically as stroke, cognitive impairment, dementia, or gait disturbance. It is generally accepted that endothelial dysfunction, including blood‐brain barrier (BBB) failure, is pivotal in the pathophysiology. Recent years have seen increasing use of imaging, primarily dynamic contrast‐enhanced magnetic resonance imaging, to assess BBB leakage, but there is considerable variability in the approaches and findings reported in the literature. Although dynamic contrast‐enhanced magnetic resonance imaging is well established, challenges emerge in cSVD because of the subtle nature of BBB impairment. The purpose of this work, authored by members of the HARNESS Initiative, is to provide an in‐depth review and position statement on magnetic resonance imaging measurement of subtle BBB leakage in clinical research studies, with aspects requiring further research identified. We further aim to provide information and consensus recommendations for new investigators wishing to study BBB failure in cSVD and dementia.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 93

1. 1.

   Wardlaw J.M., Smith C., Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497.

   Not in our library10.1016/s1474-4422(13)70060-7

2. 2.

   Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.

   Not in our library10.1016/s1474-4422(13)70124-8

3. 3.

   Blair G.W., Hernandez M.V., Thrippleton M.J., Doubal F.N., Wardlaw J.M. Advanced neuroimaging of cerebral small vessel disease. Curr Treat Options Cardiovasc Med. 2017;19:56.

   Not in our library10.1007/s11936-017-0555-1

4. 4.

   Blair G.W., Appleton J.P., Law Z.K., Doubal F., Flaherty K., Dooley R. Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination. Int J Stroke. 2018;13:530-538.

   Not in our library10.1177/1747493017731947

5. 5.

   Farrall A.J., Wardlaw J.M. Blood-brain barrier: Ageing and microvascular disease–systematic review and meta-analysis. Neurobiol Aging. 2009;30:337-352.

   Not in our library10.1016/j.neurobiolaging.2007.07.015

6. 6.

   Heye A.K., Culling R.D., Valdes Hernandez Mdel C., Thrippleton M.J., Wardlaw J.M. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 2014;6:262-274.

   Not in our library10.1016/j.nicl.2014.09.002

7. 7.
   Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability · 2016

   No notice
8. 8.

   Sourbron S.P., Buckley D.L. Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013;26:1004-1027.

   Not in our library10.1002/nbm.2940

9. 9.

   Smith E.E., Biessels G.J., De Guio F., de Leeuw F.E., Duchesne S., During M. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration. Alzheimers Dement (Amst). 2019;11:191-204.

   Not in our library10.1016/j.dadm.2019.01.002

10. 10.
    Imaging biomarker roadmap for cancer studies · 2016

    No notice
11. 11.

    Taheri S., Gasparovic C., Huisa B.N., Adair J.C., Edmonds E., Prestopnik J. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke. 2011;42:2158-2163.

    Not in our library10.1161/strokeaha.110.611731

12. 12.

    Zhang C.E., Wong S.M., van de Haar H.J., Staals J., Jansen J.F., Jeukens C.R. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology. 2017;88:426-432.

    Not in our library10.1212/wnl.0000000000003556

13. 13.

    Huisa B.N., Caprihan A., Thompson J., Prestopnik J., Qualls C.R., Rosenberg G.A. Long-term blood-brain barrier permeability changes in Binswanger disease. Stroke. 2015;46:2413-2418.

    Not in our library10.1161/strokeaha.115.009589

14. 14.

    Hanyu H., Asano T., Tanaka Y., Iwamoto T., Takasaki M., Abe K. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord. 2002;14:1-6.

    Not in our library10.1159/000058326

15. 15.

    Starr J.M., Farrall A.J., Armitage P., McGurn B., Wardlaw J. Blood-brain barrier permeability in Alzheimer's disease: A case-control MRI study. Psychiatry Res. 2009;171:232-241.

    Not in our library10.1016/j.pscychresns.2008.04.003

16. 16.

    Raja R., Rosenberg G.A., Caprihan A. MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies. Neuropharmacology. 2017;134:259-271.

    Not in our library10.1016/j.neuropharm.2017.10.034

17. 17.

    Montagne A., Barnes S.R., Sweeney M.D., Halliday M.R., Sagare A.P., Zhao Z. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296-302.

    Not in our library10.1016/j.neuron.2014.12.032

18. 18.

    Zhang C.E., Wong S.M., Uiterwijk R., Backes W.H., Jansen J.F.A., Jeukens C. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging. Brain Imaging Behav. 2019;13:389-395.

    Not in our library10.1007/s11682-018-9855-7

19. 19.

    Wang H., Golob E.J., Su M.Y. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006;24:695-700.

    Not in our library10.1002/jmri.20669

20. 20.

    Bronge L., Wahlund L.O. White matter lesions in dementia: an MRI study on blood-brain barrier dysfunction. Dement Geriatr Cogn Disord. 2000;11:263-267.

    Not in our library10.1159/000017248

21. 21.

    Munoz Maniega S., Chappell F.M., Valdes Hernandez M.C., Armitage P.A., Makin S.D., Heye A.K. Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab. 2017;37:644-656.

    Not in our library10.1177/0271678x16635657

22. 22.

    Topakian R., Barrick T.R., Howe F.A., Markus H.S. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosur Psychiatry. 2010;81:192-197.

    Not in our library10.1136/jnnp.2009.172072

23. 23.

    Wardlaw J.M., Doubal F., Armitage P., Chappell F., Carpenter T., Munoz Maniega S. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol. 2009;65:194-202.

    Not in our library10.1002/ana.21549

24. 24.

    Wardlaw J.M., Doubal F.N., Valdes-Hernandez M., Wang X., Chappell F.M., Shuler K. Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke. 2013;44:525-527.

    Not in our library10.1161/strokeaha.112.669994

25. 25.

    Wardlaw J.M., Farrall A., Armitage P.A., Carpenter T., Chappell F., Doubal F. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke. 2008;39:1327-1332.

    Not in our library10.1161/strokeaha.107.500124

26. 26.

    Wardlaw J.M., Makin S.J., Hernandez M.C.V., Armitage P.A., Heye A.K., Chappell F.M. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: Evidence from a cohort study. Alzheimers Dement. 2017;13:634-643.

    Not in our library

27. 27.

    Starr J.M., Wardlaw J., Ferguson K., MacLullich A., Deary I.J., Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003;74:70-76.

    Not in our library10.1136/jnnp.74.1.70

28. 28.

    Israeli D., Tanne D., Daniels D., Last D., Shneor R., Guez D. The application of MRI for depiction of subtle blood brain barrier disruption in stroke. Int J Biol Sci. 2011;7:1-8.

    Not in our library10.7150/ijbs.7.1

29. 29.

    van de Haar H.J., Jansen J.F.A., van Osch M.J.P., van Buchem M.A., Muller M., Wong S.M. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging. Neurobiol Aging. 2016;45:190-196.

    Not in our library10.1016/j.neurobiolaging.2016.06.006

30. 30.

    van de Haar H.J., Burgmans S., Jansen J.F., van Osch M.J., van Buchem M.A., Muller M. Blood-brain barrier leakage in patients with early alzheimer disease. Radiology. 2016;281:527-535.

    Not in our library10.1148/radiol.2016152244

31. 31.

    Li Y., Li M., Zuo L., Shi Q., Qin W., Yang L. Compromised blood-brain barrier integrity is associated with total magnetic resonance imaging burden of cerebral small vessel disease. Front Neurol. 2018;9:221.

    Not in our library10.3389/fneur.2018.00221

32. 32.

    Staals J., Makin S.D., Doubal F.N., Dennis M.S., Wardlaw J.M. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228-1234.

    Not in our library10.1212/wnl.0000000000000837

33. 33.

    Armitage P.A., Farrall A.J., Carpenter T.K., Doubal F.N., Wardlaw J.M. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn Reson Imaging. 2011;29:305-314.

    Not in our library10.1016/j.mri.2010.09.002

34. 34.

    Cramer S.P., Larsson H.B. Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: A simulation and in vivo study on healthy subjects and multiple sclerosis patients. J Cereb Blood Flow Metab. 2014;34:1655-1665.

    Not in our library10.1038/jcbfm.2014.126

35. 35.

    Barnes S.R., Ng T.S., Montagne A., Law M., Zlokovic B.V., Jacobs R.E. Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med. 2016;75:1967-1977.

    Not in our library10.1002/mrm.25793

36. 36.

    Wong S.M., Jansen J.F.A., Zhang C.E., Staals J., Hofman P.A.M., van Oostenbrugge R.J. Measuring subtle leakage of the blood-brain barrier in cerebrovascular disease with DCE-MRI: Test-retest reproducibility and its influencing factors. J Magn Reson Imaging. 2017;46:159-166.

    Not in our library10.1002/jmri.25540

37. 37.

    Lupo J.M., Cha S., Chang S.M., Nelson S.J. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: Characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005;26:1446-1454.

    Not in our library

38. 38.

    Thornhill R.E., Chen S., Rammo W., Mikulis D.J., Kassner A. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation. AJNR Am J Neuroradiol. 2010;31:1015-1022.

    Not in our library10.3174/ajnr.a2003

39. 39.

    Arba F., Leigh R., Inzitari D., Warach S.J., Luby M., Lees K.R. Blood-brain barrier leakage increases with small vessel disease in acute ischemic stroke. Neurology. 2017;89:2143-2150.

    Not in our library10.1212/wnl.0000000000004677

40. 40.

    Rost N.S., Cougo P., Lorenzano S., Li H., Cloonan L., Bouts M.J. Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke. J Cereb Blood Flow Metab. 2018;38:75-86.

    Not in our library10.1177/0271678x17706449

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.